We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
39 hedge funds and large institutions have $23.9M invested in Fate Therapeutics in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less capital invested
Capital invested by funds: $28.2M → $23.9M (-$4.28M)
15% less funds holding
Funds holding: 46 → 39 (-7)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
39
Holders Change
-7
Holders Change %
-15.22%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
9
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$1.25M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$529K |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$325K |
| 4 |
Goldman Sachs
New York
|
-$250K |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$149K |
